SpaceX Rises, Qualcomm Gains, Roivant Climbs After Lung Drug Study Meets Main Goal
Stock Movers
SpaceX Rises, Qualcomm Gains, Roivant Climbs After Lung Drug Study Meets Main Goal
00:00 / 03:11